Advertisement
Business

Regional Ambulatory Surgery Centers Are Quietly Selling to USPI Networks

The Quiet Consolidation Reshaping Outpatient Surgery

Ambulatory surgery centers built by independent physician groups over the past two decades are changing hands at a pace that would have been hard to imagine ten years ago. The buyers are not hospitals or private equity firms acting alone – they are increasingly United Surgical Partners International, the USPI network majority-owned by Tenet Healthcare, which has been systematically acquiring regional ASCs across the country with little fanfare and even less public scrutiny.

These deals rarely generate press releases. A surgery center in a mid-sized metro quietly transitions its ownership structure, staff stays in place, scheduling systems update, and the branding shifts within a few months. To patients, nothing appears to change. Behind the scenes, the economics of the facility have been completely restructured under a national network with centralized contracting, supply chain leverage, and a standardized operating model that individual physician-owners simply cannot replicate on their own.

A clean, modern ambulatory surgery center corridor with medical equipment visible
Photo by https://kaboompics.com/ / Pexels

Why Independent ASC Owners Are Selling Now

The timing is not accidental. Independent ASC operators are facing compounding cost pressures – staffing shortages have driven up labor expenses significantly, implant costs for orthopedic and spine procedures continue to climb, and commercial payers have grown increasingly aggressive in contract negotiations with facilities that lack the volume to push back. A solo surgery center in a mid-sized market negotiates from a weak position compared to a regional network, and a regional network is outgunned by a national platform with thousands of cases annually across dozens of specialties.

Physician-owners who built these centers in their fifties are also aging into the question of succession. Selling to USPI does not necessarily mean exiting – many deals are structured so founding physicians retain a minority equity stake and continue operating in the facility. The appeal is straightforward: the physician keeps a meaningful share of a more efficiently run, better-contracted center while offloading the administrative burden of ownership. It is a partial liquidity event that does not require walking away from the practice you spent years building.

There is also a regulatory dimension driving urgency. Certificate of Need laws vary by state, and where they exist they limit how many new ASCs can enter a market. In states without CON protections, competition from hospital outpatient departments and new entrants has squeezed margins on bread-and-butter procedures like colonoscopies, cataract removals, and pain management injections. USPI’s ability to shift higher-acuity, higher-margin cases – total joints, spine, cardiac – into acquired centers makes those facilities immediately more profitable than their previous owners could have achieved independently.

Healthcare professionals reviewing documents in a professional conference room setting
Photo by RDNE Stock project / Pexels

What USPI Is Actually Buying

USPI is not primarily buying buildings or equipment. It is buying contracted relationships – both with commercial payers and with the physician groups who bring cases to the facility. Those two assets are deeply intertwined. A surgery center that has maintained stable, loyal surgical staff and favorable payer contracts for a decade is worth considerably more than its physical plant suggests.

The network effect matters here in a way that is often underappreciated. Once USPI acquires enough volume in a geographic region, it can negotiate contracts as a multi-site network rather than a single facility – a dynamic that immediately changes the rate conversation with every major insurer in the market. This is the same consolidation logic playing out across other healthcare verticals, including regional dialysis clinics selling to DaVita networks, where scale with payers becomes the primary value driver after acquisition.

The Financial Structure of These Deals

USPI typically acquires a majority ownership stake – often in the range of 51 percent – while allowing physician partners and sometimes health system co-investors to retain the remainder. Tenet Healthcare’s overall corporate strategy treats ASC ownership as a higher-margin, capital-light complement to its acute care hospital business, and USPI is the vehicle for building that portfolio at scale. The acquisition targets are not distressed facilities. USPI is buying centers that are already profitable, already well-run, and already embedded in their local physician communities – it is paying for quality and then extracting efficiency gains on top of it.

Valuation multiples for well-performing ASCs have remained elevated even as deal volume has grown. Buyers like USPI are willing to pay a premium because they know they can improve EBITDA margins through centralized purchasing, revenue cycle management upgrades, and case mix optimization. Independent sellers who wait too long risk watching those multiples compress if payer pressure or competing market entrants erode the center’s underlying profitability before a sale closes.

The supply chain element alone often justifies the purchase price from USPI’s perspective. A standalone ASC buying implants for orthopedic procedures negotiates essentially as an individual customer. Inside a network of hundreds of centers, that same implant purchase is part of a national contract negotiated with vendors who have every incentive to offer steep volume discounts. The margin recapture from that single change can be substantial enough to accelerate the payback period on the acquisition considerably.

Surgical team working in an outpatient operating room environment
Photo by Weverton Oliveira / Pexels

For the physicians who stay on as minority partners post-acquisition, the calculus shifts in ways that are not always comfortable to articulate. They gain financial stability and operational support, but they lose the kind of unilateral control that made building an independent center attractive in the first place. Decisions about which payer contracts to accept, which service lines to expand, and how to allocate capital now flow through a corporate approval process. Some founding physicians describe this trade-off as worth it. Others who have been through the transition describe a creeping sense of distance between the center they built and the facility they now practice in – even when the name on the door has not changed.

Related Articles